Michaela Levin Email & Phone Number

Salt Lake City, Utah, Us

Oxford, Oxfordshire, Gb

Lead due diligence and therapeutic asset transactions. Focused portfolio and regulatory strategy to strengthen Exscientia's pipeline by prioritizing high value oncology and rare disease assets, thereby positioning the company for a merger/combination. Source and lead in- and outlicensing opportunities of therapeutic assets in oncology and rare diseases to maximize value of Exscientia's early development as well as their clinical stage pipeline.

Cambridge, Massachusetts, Us

Developed and led business development growth strategies to select for global partners to accelerate path to marketBuilt product strategies and refocused Editas pipeline around hemoglobinopathies and in-vivo to maximize portfolio valueSourced and led due diligence, negotiated multiple term sheets and executed multiple multi-million dollar licenses

New York, New York, Us

Sourced and lead in/out-licensing deals, and commercial and academic collaborations. Closed deal value >$150M in rare neurological diseases and epilepsy. Led due diligence teams to evaluate global opportunities.

Led $1.7B acquisition deal of Constellation Pharma by MorphoSys AG (July 2021). Created roadmap of Constellation integration into MorphoSys and led cross-functional teams. Performed search and evaluation toward in- and out-licensing and collaborations focusing on oncology, hematological malignancies and rare diseases. Led cross-functional teams to support corporate strategy and portfolio integration. Built and executed strategic commercialization and financing initiatives, received net proceeds of $242M in 2019, and $181M in 2020 in public offerings.

Managed the Neuroscience / Neurology portfolio of Brigham & Women's Hospital and Radiation Oncology portfolio of Massachusetts General Hospital (therapeutics, biomarkers, diagnostics, medical devices, and research tools); facilitate commercialization of new technologies through start-ups and license deals.Led negotiations of deal terms on license, option, research collaboration, and inter-institutional agreements; work with physicians/scientists to foster industry partnerships; manage patent portfolios and prosecution to protect the intellectual property of the most promising medical innovations at BWH and MGH. 2018 Partners Top Performer Award

Identify business development opportunities and potential partnerships and alliances. Develop licensing strategy and negotiate and execute licensing agreements for life science technologies. Assist with clinical strategies.

Philadelphia, Pa, Us

Assisted in drafting and prosecuting patent applications in the practice areas of biotechnology, pharmaceuticals and a wide range of technologies. Aids in preparing patentability, invalidity, infringement and freedom to operate searches and opinions on US and international inventions.

Cambridge, Massachusetts, Us

Commercialized and protected innovative technologies in the life sciences and medical devices for Harvard University's OTD at Harvard Medical School and fostered and managed strategic collaborations with industry partners. Performed strategic, commercial/market, and financial analyses.

Boston, Ma, Us

In the Rotenberg lab I validated new epileptogenic targets and examined the biophysical properties of hippocampal neurons in epilepsy and traumatic brain injury models. To modulate cortical excitability I used transcranial direct current stimulation (tDCS) in patients suffering from refractory status epileticus and in murine epilepsy models. Specifically, I looked at the role of axonal and dendritic orientation relative to the direct current stimulus vector in neuromodulation. To examine the biophysical properties of these neuronal structures I used extracellular and whole cell patch-clamp recordings. In addition, I recorded evoked field potentials in neurons from post-surgical cortical slices from human brain tissue from patients suffering epilepsy using multi-electrode arrays. Thus, I could record from the different regions of the hippocampus while stimulating in one specific region tracking pathways of increased neuronal activity.

Charlottesville, Va, Us

Summary: Electrophysiology, Patch-Clamp Recordings, Preclinical Testing in Diabetes Mouse Model, Molecular Biology, Immunohistochemistry, Potassium Ion Channels, Inner Ear ResearchResearch Description: In the Holt/Géléoc lab my research focused on identifying the biophysical properties of potassium ion channels in the inner ear. Using molecular biology I looked at developmental expression levels and potential effects of ion channel mutations on the function of the maturing hair cell. To examine the biophysical properties of these ion channels I use predominantly whole cell patch-clamp recordings.Research collaboration: preclinical research in pathophysiology and development of painful diabetic neuropathy. I conducted animal behavioral tests in leptin-deficient (ob/ob) mice which included intraperitoneal dosing of mice.In addition, I researched serotonergic and dopaminergic systems in Drosophila. Using immunohistochemistry I described serotonergic and dopaminergic morphology and used HPLC to screen for serotonin and dopamine levels. I screened for candidate serotonin receptors with PCR, HPLC, in situ hybridization and Western Blot. Further, in a collaborative study I used electron microscopy to locate serotonin receptors in brain slices of mice.

Jazz and Classical Performances solo and with ensemble, Music lessons in Saxophone, Flute, Clarinet, and Piano, Jazz and Classical Music Theory, Jazz Composition and Arrangement

Charlottesville, Va, Us

Immunohistochemistry, Confocal Microscopy, Electron Microscopy, Serotonergic and Dopaminergic Systems in Drosophila and their role in Depression Disorders.

Phd, Neuroscience

Jazz Diploma, Jazz Performance

Ma, Performance And Composition